Germany-based cultivated meat company MyriaMeat has unveiled its latest innovation, the ‘world’s first’ cell-based pork fillet.
The company introduced the groundbreaking product last week at an event hosted by the SPRIND Federal Agency for Jump Innovations in Berlin.
MyriaMeat’s product, made from cultivated pig cells, is 100% real meat – without hybrid additions of soy or other plant substances, which are commonly found in many cultivated meat products.
Malte Tiburcy, co-founder of MyriaMeat and research lead at the University of Göttingen, said: “Our meat is free from vegetable additives and genetic modifications”.
Developed in the laboratory at MyriaMeat’s Life Science factory in Göttingen, the cultivated pork fillet represents a significant step towards a more ethical and environmentally friendly future of meat production.
The company’s CEO Florian Hüttner said: "Our unique induced pluripotent stem cell (iPSC) pipeline allows us to obtain stable stem cell cultures from a single, harmless biopsy. Our vision is to redefine meat consumption in line with the needs of a growing world population and environmental protection, significantly reducing the CO2 emissions of meat production."
He continued: “At our company, it's now about implementation, no longer basic research, and we have demonstrated this with our prototype developed in Göttingen within just one year. At MyriaMeat, we have built a platform not only for the production of high-quality and pure meat but also for a variety of other meat-based products and are an ideal partner for the development of innovative foods with alternative proteins."
MyriaMeat said that investments from its founders and funding from the SPRIND Federal Agency for Jump Innovations enabled it to achieve this technological milestone, its pork fillet prototype, marking the transition from basic research to application.
MyriaMeat has entered into discussions with industrial partners and potential investors to prepare for scaling and a first tasting event later this year.
.png)